Bayer pledges $300M to boost production in world's 'contraceptive capital’

Bayer pledges $300M to boost production in world's 'contraceptive capital’

Source: 
Fierce Pharma
snippet: 

Bayer, currently in the midst of a gung-ho cell therapy expansion in the U.S., is turning its attention back to Europe as it looks to beef up its birth control manufacturing in the world's "contraceptive capital."